1 / 79

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD. PRESENTATION TO THE PORTFOLIO COMMITTEE: 7 NOVEMBER 2006. PRESENTATION OUTLINE. Introduction & Governance Report (Ms N D Shabalala, Board Chairperson) Company Performance (Dr L C N Makuleni, Managing Director) Human Resource Report

sef
Télécharger la présentation

ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD PRESENTATION TO THE PORTFOLIO COMMITTEE: 7 NOVEMBER 2006

  2. PRESENTATION OUTLINE • Introduction & Governance Report (Ms N D Shabalala, Board Chairperson) • Company Performance (Dr L C N Makuleni, Managing Director) • Human Resource Report (Ms S A Bokwe, GM: Human Resources) • Financial Performance for 2005/06 (Mr M P van Jaarsveld, GM: Finance) • Conclusion (Dr L C N Makuleni & Ms N D Shabalala)

  3. THE OBP BOARD Front (LtR): Dr Linda Makuleni (Managing Director), Ms Nozibusiso Shabalala (Board Chair) Back (LtR) Mr Montwedi Seane, Ms Stefanie Burger (Company Secretary), Adv Dave Mitchell, Dr Ruth Forbes

  4. THE OBP LTD EXECUTIVE TEAM Front (LtR) Dr Linda Makuleni (MD), Mr Willie Botha (National Sales Manager) Back (LtR) Mr Pieter Pieterson (GM: TQM), Dr Alfred Kgasi (Business Development Manager), Ms Siphokazi Bokwe (GM: HR), Dr Baty Dungu (GM: Ops, R & D) Mr Pierre v Jaarsveld (GM: Finance)

  5. GOVERNANCE REPORT

  6. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD • The Board retains full and effective control of the Company • To this end, the Board met 6 times • The Board is committed towards Good Corporate Governance: • Induction of Directors • Director Development Programme • Conducted assessment of Board and Board Committees

  7. CORPORATE GOVERNANCE – FUNCTIONING OF BOARD AND COMMITTEES • Annual Board Plan – considering Reporting requirements: • Quarterly Board Meetings • Three Meetings of Committees per annum • Two Strategy Planning & Review Sessions per annum

  8. FUNCTIONING OF BOARD COMMITTEES • Remuneration Committee: • Board approved Committee Charter • 3 Meetings to deal with 2005/06 matters • Membership: • Dr M Madikizela (Chairperson) • Adv D J Mitchell • Mr S S M Seane • Ms N D Shabalala • Ms S A Bokwe (GM: Human Resource) • MD, GM: Finance (by invitation)

  9. FUNCTIONING OF BOARD COMMITTEES • Remuneration Committee Activities: • Remuneration of: • Directors • Executives • Employees • Performance Assessment of Executives • Human Resource Matters

  10. FUNCTIONING OF BOARD COMMITTEES • Audit Committee: • Board approved Committee Charter • 3 Meetings to deal with 2005/06 matters • Membership: • Adv D J Mitchell (Chairperson) • Dr R U Forbes • Ms N D Shabalala • Mr M P van Jaarsveld (GM: Finance) • MD, Internal Auditor, External Auditors (by invitation)

  11. FUNCTIONING OF BOARD COMMITTEES • Audit Committee Activities: • Effectiveness of Internal Controls • Internal Audit • External Audit • Financial Matters • Management Accounts • Investments • Financial Policies • Annual Financial Statements and Annual Report

  12. FUNCTIONING OF BOARD COMMITTEES • Risk Management Committee: • Board approved Committee Charter • 3 Meetings to deal with 2005/06 matters • Membership: • Dr R U Forbes (Chairperson) • Adv D J Mitchell • Ms N D Shabalala • Dr L C Makuleni (Managing Director)

  13. FUNCTIONING OF BOARD COMMITTEES • Risk Management Committee: • Membership (Continued): • Dr B Dungu (GM: Ops, R & D) • Mr P M Pieterson (GM: Total Quality) • GM: Finance, Internal Audit, EMU Manager (by invitation) • Risk Management Committee Activities • Annual Risk Assessment • Annual Risk Management Plan • Risk Management – Continuous monitoring and evaluation of Risk Management plan

  14. FUNCTIONING OF BOARD COMMITTEES • Research and Development Committee: • Board approved Committee Charter • 3 Meetings to deal with 2005/06 matters • Membership: • Mr S S M Seane (Chairperson) • Dr M Madikizela • Dr L C Makuleni (Managing Director) • Dr B Dungu (GM: Operations, R & D) • National Sales Manager (by invitation)

  15. FUNCTIONING OF BOARD COMMITTEES • Research and Development Committee Activities: • R&D Strategy and Policy • Intellectual Property Management • Monitor and evaluate Strategic R&D Projects

  16. OCCUPATIONAL HEALTHAND SAFETY COMMITTEE • Reports Quarterly to the Board • 7 Meetings to deal with 2005/06 matters • Membership: • Ms S Burger (Company Secretary) • Mr P M Pieterson (GM: Total Quality) • Mr L Gcwensa (Labour Relations Manager) • Mr B Shandu (Manager: Engineering, Maintenanceand Utilities)

  17. OCCUPATIONAL HEALTHAND SAFETY COMMITTEE • Committee Activities: • Legal Compliance • Policy • Strategy

  18. COMPANY PERFORMANCE: 2005/06

  19. COMPANY PERFORMANCE: • FINANCIAL • OPERATIONS • RESEARCH AND DEVELOPMENT • TOTAL QUALITY MANAGEMENT

  20. Onderstepoort Biological Products Ltd has become a respected leader in its niche market: the production and sale of animal vaccines and related biological products.

  21. COMPANY PERFORMANCE • FINANCIAL • Sales History • Sales compared to budget & last year • Operational Profits

  22. COMPANY PERFORMANCE:FINANCIAL Annual Sales History:

  23. COMPANY PERFORMANCE:FINANCIAL

  24. COMPANY PERFORMANCE:FINANCIAL

  25. COMPANY PERFORMANCE: DOMESTIC SALES & MARKETING • Building partnerships with: • Provincial Departments of Veterinary Service • Veterinarians • Commodity Groups • Emerging and Commercial Farmers • Expert panel meeting • Customer Survey

  26. COMPANY PERFORMANCE: DOMESTIC SALES & MARKETING • Sponsorships • Female farmer of the year • NERPO • SAVA congress • Farmers’ days • Extended distribution network • Major agreements with BEE companies

  27. COMPANY PERFORMANCE: EXPORT SALES & MARKETING • Appointment of Business Development Manager • Interacted with existing and prospective Export Clients • Developed Strategies for different Export Regions

  28. COMPANY PERFORMANCE: EXPORT SALES & MARKETING • Attended International Conferences and presentedTechnical Papers • Sponsorships: • FAO • Botswana & Namibian Veterinary Congresses

  29. COMPANY PERFORMANCE: RESEARCH AND DEVELOPMENT • License Technology & Strategic Partnerships • 3 Research and Development Projects on Trans-Boundary Diseases • Other Strategic Projects • IP Management

  30. COMPANY PERFORMANCE: OPERATIONS • Facility Upgrade • Physical Infrastructure Audit • Facility Upgrade Plan • Streamlining Production Processes • Production Planning Processes

  31. COMPANY PERFORMANCE: OPERATIONS

  32. COMPANY PERFORMANCE: TOTAL QUALITY MANAGEMENT • Experimental Animals • Animal Ethics • Co-operation with other Government Departmentsfor animal housing

  33. COMPANY PERFORMANCE: TOTAL QUALITY MANAGEMENT • Quality Assurance: • Supplier Quality and BEE Audits • Plant Quality Audits • Planning of first external ISO audit • Regulatory Office: • Review of current registered product dossiers • Registration of OBP products Internationally

  34. HUMAN RESOURCE REPORT: 2005/06

  35. HUMAN RESOURCES • Employment Equity Report • Human Resource Development • HIV/ AIDS • Remuneration • Social Responsibility

  36. EQUITY STATUS REPORTEMPLOYEE DISTRIBUTION BY RACE

  37. EQUITY STATUS REPORTEMPLOYEMENT EQUITY 2005/06

  38. EQUITY STATUS REPORTEMPLOYEE DISTRIBUTION BY GENDER: 2004/5 vs. 2005/6

  39. EQUITY STATUS REPORTSTAFF WITH DISABILITY

  40. HUMAN RESOURCES DEVELOPMENT • Areas of focus • ABET • Bursaries • Multi-skilling • In-House Technical Training • Management Development Programme

  41. TRAINING AND DEVELOPMENT

  42. PERCENTAGE OF TRAINING COSTS PER OCCUPATIONAL CATEGORY

  43. HIV/ AIDS • Launched company strategy on HIV/ AIDS • KAPB study conducted • OBP’s statement of intent was signed by the Managing Director on World Aids day in 2005

  44. REMUNERATION • We strive to offer competitive salaries • Remuneration based on performance and scarcity of skills • Survey market yearly as part of 3 year agreement

  45. RETENTION • Staff Complement: 207 • Labour Turnover- 3% • Management Turnover – 0% • 56 % of staff- employed longer than 10 years • Turnover in staff recruited since Corporatisation - 1% • Climate Survey conducted

  46. OBP SOCIAL RESPONSIBILITY • Take a girl child to work • Participated in Cell C take a girl child to work

  47. OBP SOCIAL RESPONSIBILITY • Internship Programme for Engineers • Two appointed within the Company, of which one received a better offer • Experiential training of Scientists (Landbank / OBP Collaboration) • Accommodated two graduates for experiential training for a period of twelve months • Partnerships with Service Providers: • Students placed with OBP Service Providers for experiential training (e.g. Stuart – Scott)

  48. OBP SOCIAL RESPONSIBILITY • Tumeleng Mission (Klipgat) • Hospice • Crèche • Children’s home • Donated our time and money

More Related